These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6832476)

  • 1. Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice.
    Rousset JP; Bucchini D; Jami J
    Dev Biol; 1983 Apr; 96(2):331-6. PubMed ID: 6832476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hybrids between F9 "nullipotent" teratocarcinoma and rat thymus cells produce differentiated cells].
    Hsu WM; Song QB; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):177-87. PubMed ID: 3835750
    [No Abstract]   [Full Text] [Related]  

  • 3. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells.
    Atsumi T; Shirayoshi Y; Takeichi M; Okada TS
    Differentiation; 1982; 23(1):83-6. PubMed ID: 7152170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent teratocarcinoma-thymus somatic cell hybrids.
    Miller RA; Ruddle FH
    Cell; 1976 Sep; 9(1):45-55. PubMed ID: 61820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine embryonal carcinoma hybrids: decreased ability to spontaneously differentiate as a dominant trait.
    Oshima RG; McKerrow J; Cox D
    J Cell Physiol; 1981 Nov; 109(2):195-204. PubMed ID: 7197684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A strategy for immortalizing lines committed to endoderm, neuroectoderm or mesoderm from mouse teratocarcinoma].
    Buc-Caron MH; Launay JM; Marie PJ; Kellermann O
    Reprod Nutr Dev; 1990; 30(3):309-16. PubMed ID: 2168713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of the cDNAs corresponding to mRNAs abundant in undifferentiated mouse embryonal teratocarcinoma stem cells, but not in differentiated mouse parietal endoderm cells.
    Ikuma S; Kiyota M; Setoyama C; Shimada K
    J Biochem; 1986 Nov; 100(5):1185-92. PubMed ID: 2434467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of teratocarcinoma-thymus somatic cell hybrids.
    Miller RA; Ruddle FH
    Somatic Cell Genet; 1977 May; 3(3):247-61. PubMed ID: 605385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalization of precursors of endodermal, neuroectodermal and mesodermal lineages, following the introduction of the simian virus (SV40) early region into F9 cells.
    Kellermann O; Buc-Caron MH; Gaillard J
    Differentiation; 1987; 35(3):197-205. PubMed ID: 2833421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental potentialities and surface antigens of mouse teratocarcinoma x lymphoid cell hybrids.
    Rousset JP; Jami J; Dubois P; Avilès D; Ritz E
    Somatic Cell Genet; 1980 May; 6(3):419-33. PubMed ID: 7404272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cellular oncogenes in teratoma-derived cell lines.
    Sejersen T; Sümegi J; Ringertz NR
    Exp Cell Res; 1985 Sep; 160(1):19-30. PubMed ID: 2412863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-promoting effects of mammary-derived growth inhibitor (MDGI) on pluripotent mouse embryonic stem cells.
    Wobus AM; Zschiesche W; Grosse R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(6):339-42. PubMed ID: 1981402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a human ovarian teratocarcinoma-derived cell line.
    Zeuthen J; Nørgaard JO; Avner P; Fellous M; Wartiovaara J; Vaheri A; Rosén A; Giovanella BC
    Int J Cancer; 1980 Jan; 25(1):19-32. PubMed ID: 6931103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental characteristics of somatic cell hybrids between totipotent mouse teratocarcinoma and rat intestinal villus cells.
    van der Kamp AW; Roza-de Jongh EJ; Houwen RH; Magrane GG; van Dongen JM; Evans MJ
    Exp Cell Res; 1984 Sep; 154(1):53-64. PubMed ID: 6381077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinate expression of parietal endodermal functions in hybrids of embryonal carcinoma and endodermal cells.
    Howe WE; Oshima RG
    Mol Cell Biol; 1982 Mar; 2(3):331-7. PubMed ID: 7202115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
    Chan SD; Strewler GJ; King KL; Nissenson RA
    Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of teratomas from the ectoderm of mouse egg cylinders.
    Diwan SB; Stevens LC
    J Natl Cancer Inst; 1976 Oct; 57(4):937-42. PubMed ID: 1003535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological analysis of early mouse embryo with rat monoclonal antibodies produced against mouse teratocarcinoma cells.
    Hamasima N; Seto M; Momoi T; Takahashi T
    Differentiation; 1985; 28(3):260-7. PubMed ID: 3838958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonal carcinoma cells (and their somatic cell hybrids) are resistant to infection by the murine parvovirus MVM, which does infect other teratocarcinoma-derived cell lines.
    Miller RA; Ward DC; Ruddle FH
    J Cell Physiol; 1977 Jun; 91(3):393-401. PubMed ID: 558990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.